 |
|
|
|
|
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Schlossmacher M. on LIVE DISCUSSION: Herpes Simplex and Alzheimer’s—Time to Think Again?, I have been intrigued by these ideas since Itzhaki and others presented some of the data in... 17 Feb 2011.
|
|
|
 |
|
|
Schlossmacher M. on PAPER: Chartier-Harlin MC. et al., 2004 Sep 25-Oct 1, In recent months, the field of Parkinson disease (PD) has seen several exciting research... 17 Jan 2005.
|
|
|
|
|
|
Schlossmacher M. on NEWS: Pink Mutations Link Parkinson’s Disease to Mitochondria, The two exciting reports in ScienceExpress of two discoveries, one, the mutant Pink1 gene at the... 29 Apr 2004.
|
|
|
|
|
|
Schlossmacher M. on NEWS: Synuclein and Parkinson's—It's All in the Dose, These two exciting articles provide significant momentum for the field of Parkinson's disease... 4 Nov 2003.
|
|
|
|
|
|
Schlossmacher M. on NEWS: New Parkinson’s Gene: DJ Mutations Make Neurons Change Their Tune, I fully agree with the previous comments. DJ-1 as the gene product of the
PARK7 locus indeed... 2 Dec 2002.
|
|
|
|
|
|
Schlossmacher M. on NEWS: Dopamine Renders α-Synuclein Toxic to Neurons, I found this paper quite intriguing and very much relevant to PD. I believe it provides a very... 31 May 2002.
|
|
|
|
|
|
Schlossmacher M. on NEWS: Presenting: A Not-Quite-Parkinson's Mouse Model, As is often the case with transgenic rodent models of human neurodegenerative diseases, a single... 20 May 2002.
|
|
|
|
|
|
Schlossmacher M. on LIVE DISCUSSION: Picking up the Pieces of Parkin
, Three principal issues arise from the literature reviewed by Dr. Wolozin and his comments: (1)... 17 Jan 2002.
|
|
|
|
|
|
Schlossmacher M. on NEWS: Molecular Chaperones Can Ameliorate Neuronal Loss in Drosophila PD Model, This report is relevant both from the perspectives of pathogenesis
(i.e., does chaperone... 21 Dec 2001.
|
|
|
|
|
|
|
1 to 9 of 9 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
